Coronavirus COVID19 vaccine: WHO cautions after Russia claims, Oxford, India, Moderna’s progress

By: |
New Delhi | Updated: Aug 04, 2020 10:46 AM

Coronavirus vaccine news update, COVID19 vaccine update: WHO director-general Tedros Adhanom Ghebreyesus has claimed that the development of an elusive vaccine that will neutralize Coronavirus and protect human beings was still not guaranteed

 Coronavirus vaccine news update, Coronavirus vaccine in India, Coronavirus vaccine Oxford, Coronavirus vaccine trials, Coronavirus vaccine Italy, Coronavirus vaccine WHO, Coronavirus vaccine Russia update, Coronavirus vaccine latest update in India, COVID19 vaccine update, COVID19 vaccine latest news, COVID19 vaccine in India, COVID19 vaccine found, COVID19 vaccine trials, COVID19 vaccine news UK, COVID19 vaccine USA, COVID19 vaccine WHO, COVID19 vaccine name, COVID19 vaccine latestCoronavirus vaccine news update, COVID19 vaccine update: The WHO stated that around 26 potential coronavirus vaccine candidates have entered the different stages of human trials around the world.

Coronavirus vaccine news update, COVID19 vaccine update: While over 165 potential Coronavirus COVID19 vaccine candidates are at different stages of development, the World Health Organisation sounded a note of caution regarding the outcome of these trials. However, in India, there is a silver lining as Serum Institute of India (SII) has been granted approval to go ahead with late-stage human trials for the experimental vaccine candidate being produced by the UK-based Oxford-AstraZeneca. India’s first indigenous Coronavirus vaccine candidate COVAXIN has also shown positive results during its Phase 1 and Phase 2 clinical trials.

Coronavirus vaccine UK, Oxford, Moderna, Russia, China

The WHO stated that around 26 potential coronavirus vaccine candidates have entered the different stages of human trials around the world. However, vaccine experts claimed that the actual number of potential COVID19 vaccines are three times what the WHO has listed. The University of Oxford-AstraZeneca’s AZD1222 or Covishield has reached Phase 3 of human trials. The US-based Moderna-NIAID’s mRNA-1273 has reached phase 3. Pfizer-BioNTech’s BNT162b2 has reached Phase 3. Chinese firms Sinovac’s vaccine candidate Coronavac has also reached Phase 3. Two candidates of another China firm Sinopharm have reached Phase 3. Russia has claimed that its coronavirus vaccine will be ready by August 12.

Coronavirus vaccine WHO

Meanwhile, WHO director-general Tedros Adhanom Ghebreyesus has claimed that the development of an elusive vaccine that will neutralize Coronavirus and protect human beings was still not guaranteed. The WHO chief said that a number of vaccines have entered the phase-III human trials. While people around the world are hoping to get a number of effective vaccines that can safeguard us from the highly contagious disease, “there is no silver bullet at the moment, and there might never be”, Tedros said. “There are concerns that we may not have a vaccine that may work or its protection could be for just a few months, not more. But until we finish the clinical trials, we will not know,” the WHO chief said.

Earlier renowned US expert on infectious diseases Anthony Fauci had also said he was “cautiously optimistic” about the development of the Coronavirus COVID19 vaccine by early 2021.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Positivity rate below 4 per cent for 5 days would mean Delhi has been successful in combating COVID-19: Satyendar Jain
2Important to have large basket of COVID-19 vaccine candidates: DBT Secy
3Delhi govt tells healthcare facilities to submit HCWs data for COVID-19 vaccination